跳至主要内容
临床试验/NCT01425320
NCT01425320撤回1 期

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

Allergan0 个研究点开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
发起方
Allergan
主要终点
Plasma Levels of Dapsone

研究概览

简要总结

This study will investigate the pharmacokinetics, safety and tolerability of dapsone and adapalene following topical administration of 2 formulations of dapsone/adapalene fixed combination gel, dapsone 5% gel (ACZONE®), and adapalene 0.3% gel (Differin®) in subjects with acne vulgaris.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Moderate acne on the face
  • Willing to avoid swimming during the study
  • Willing to avoid excessive sunlight and ultraviolet light (e.g., tanning beds)during the study
  • Willing to avoid moisturizers, sunscreens, cosmetics, and chemical peels during the study

排除标准

  • Severe cystic acne
  • Use of topical or oral retinoids within 4 weeks
  • Use of isotretinoin within 3 months
  • Use of dapsone or adapalene within 3 months
  • Anticipated need to engage in activities/exercise that would cause profuse sweating
  • Donated blood or equivalent blood loss within 90 days

研究组 & 干预措施

Fixed Combination dapsone/adapalene Formulation A Gel

Experimental

Study medication will be applied once daily for 14 days to the face, upper chest, upper back, and shoulders.

干预措施: Fixed Combination dapsone/adapalene Formulation A Gel (Drug)

Fixed Combination dapsone/adapalene Formulation B Gel

Experimental

Study medication will be applied once daily for 14 days to the face, upper chest, upper back, and shoulders.

干预措施: Fixed Combination dapsone/adapalene Formulation B Gel (Drug)

dapsone 5% gel (ACZONE®)

Active Comparator

Study medication will be applied twice daily for 14 days to the face, upper chest, upper back, and shoulders.

干预措施: dapsone 5% gel (Drug)

adapalene 0.3% gel (Differin®)

Active Comparator

Study medication will be applied once daily for 14 days to the face, upper chest, upper back, and shoulders.

干预措施: adapalene 0.3% gel (Drug)

结局指标

主要结局

Plasma Levels of Dapsone

时间窗: Day 14

Plasma Levels of Adapalene

时间窗: Day 14

次要结局

  • Local Dermal Tolerability Rating Using a 4-Point Scale(Day 14)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验